Takeda Pharmaceutical Company Limited (NYSE:TAK) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) have received a consensus rating of “Moderate Buy” from the five ratings firms that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year […]